The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.
Open accessAbstract
Resistance to Leishmania major in mice is associated with the appearance of distinct T helper type 1 (Th1) and Th2 subsets. T cells from lymph nodes draining cutaneous lesions of resistant mice are primarily interferon gamma (IFN-gamma)-producing Th1 cells. In contrast, T cells from susceptible mice are principally Th2 cells that generate interleukin 4 (IL-4). Although existing evidence is supportive of a role for IFN-gamma in the generation of Th1 cells, additional factors may be required for a protective response to be maintained. A potential candidate is IL-12, a heterodimeric cytokine produced by monocytes and B cells that has multiple effects on T and natural killer cell function, including inducing IFN-gamma production. Using an experimental leishmanial model we have observed that daily intraperitoneal administration at the time of parasite challenge of either 0.33 micrograms IL-12 (a consecutive 5 d/wk for 5 wk) or 1.0 micrograms IL-12 per mouse (only a consecutive 5 d) caused a > 75% reduction in parasite burden at the site of infection, in highly susceptible BALB/c mice. Delay of treatment by 1 wk had less of a protective effect. Concomitant with these protective effects was an increase in IFN-gamma and a decrease in IL-4 production, as measured by enzyme-linked immunosorbent assay of supernatants generated from popliteal lymph node cells stimulated with leishmanial antigen in vitro. The reduction in parasite numbers induced by IL-12 therapy was still apparent at 10 wk postinfection. In addition, we observed that the administration of a rabbit anti-recombinant murine IL-12 polyclonal antibody (200 micrograms i.p. every other day for 25 d) at the time of infection to resistant C57Bl/6 mice exacerbated disease. These effects were accompanied by a shift in IFN-gamma production in vitro by antigen-stimulated lymph node cells indicative of a Th2-like response. These findings suggest that IL-12 has an important role in initiating a Th1 response and protective immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B., & Trinchieri, G. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.827 · Cited by 1,953
Heinzel, F. P., Sadick, M. D., Holaday, B. J., Coffman, R. L., & Locksley, R. M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.59 · Cited by 1,454
D'Andrea, A., Rengaraju, M., Valiante, N. M., Chehimi, J., Kubin, M., Aste, M., Chan, S. H., Kobayashi, M., Young, D., & Nickbarg, E. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1387 · Cited by 1,144
Chan, S. H., Perussia, B., Gupta, J. W., Kobayashi, M., Pospísil, M., Young, H. A., Wolf, S. F., Young, D., Clark, S. C., & Trinchieri, G. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.4.869 · Cited by 961
Self-citationUse of staphylococcal protein A as an immunological reagent
Goding, J. W. (1978) · Journal of Immunological Methods · doi:10.1016/0022-1759(78)90259-4 · Cited by 941
Wolf, S. F., Temple, P. A., Kobayashi, M., Young, D., Dicig, M., Lowe, L., Dzialo, R., Fitz, L., Ferenz, C., & Hewick, R. M. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.9.3074 · Cited by 845
Self-citationProduction of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1
Ohara, J., & Paul, W. E. (1985) · Nature · doi:10.1038/315333a0 · Cited by 726
Scott, P., Natovitz, P., Coffman, R. L., Pearce, E., & Sher, A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.5.1675 · Cited by 705
Stern, A. S., Podlaski, F. J., Hulmes, J. D., Pan, Y. C., Quinn, P. M., Wolitzky, A. G., Familletti, P. C., Stremlo, D. L., Truitt, T., & Chizzonite, R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6808 · Cited by 670
Cited by
THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune Responses
Gately, M. K., Renzetti, L. M., Magram, J., Stern, A. S., Adorini, L., Gubler, U., & Presky, D. H. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.495 · Cited by 1,231
Herwaldt, B. L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10178-2 · Cited by 1,229
The immunology of susceptibility and resistance to Leishmania major in mice
Sacks, D., & Noben-Trauth, N. (2002) · Nature Reviews Immunology · doi:10.1038/nri933 · Cited by 1,208
CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity
Chu, R. S., Targoni, O. S., Krieg, A. M., Lehmann, P. V., & Harding, C. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1623 · Cited by 1,002
Seder, R. A., Gazzinelli, R., Sher, A., & Paul, W. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10188 · Cited by 976
New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions
Hunter, C. A. (2005) · Nature Reviews Immunology · doi:10.1038/nri1648 · Cited by 852
Yoshimoto, T., & Paul, W. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1285 · Cited by 841
Multifactorial Nature of Human Immunodeficiency Virus Disease: Implications for Therapy
Fauci, A. S. (1993) · Science · doi:10.1126/science.8235617 · Cited by 776
Interleukin-12: A Cytokine at the Interface of Inflammation and Immunity
Trinchieri, G. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60387-9 · Cited by 760
The Adjuvant Effect of Interleukin-12 in a Vaccine Against Leishmania major
Afonso, L. C. C., Scharton, T. M., Vieira, L. Q., Wysocka, M., Trinchieri, G., & Scott, P. (1994) · Science · doi:10.1126/science.7904381 · Cited by 680
Constant, S., Pfeiffer, C., Woodard, A., Pasqualini, T., & Bottomly, K. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1591 · Cited by 677
Jacobson, N. G., Szabo, S. J., Weber-Nordt, R. M., Zhong, Z., Schreiber, R. D., Darnell, J. E., & Murphy, K. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1755 · Cited by 673
Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production.
van der Pouw Kraan, T. C., Boeije, L. C., Smeenk, R. J., Wijdenes, J., & Aarden, L. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.775 · Cited by 666
Cutaneous leishmaniasis: Immune responses in protection and pathogenesis
Scott, P., & Novais, F. O. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.72 · Cited by 591
CD1d1 Mutant Mice Are Deficient in Natural T Cells That PromptlyProduce IL-4
Mendiratta, S. K., Martin, W. D., Hong, S., Boesteanu, A., Joyce, S., & Van Kaer, L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80290-3 · Cited by 595
T Helper Cell Subsets in Insulin-Dependent Diabetes
Katz, J. D., Benoist, C., & Mathis, D. (1995) · Science · doi:10.1126/science.7761837 · Cited by 593
Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.
Leonard, J. P., Waldburger, K. E., & Goldman, S. J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.381 · Cited by 547
Self-citationThe Immunobiology of the Interleukin-12 Family: Room for Discovery
Tait Wojno, E. D., Hunter, C. A., & Stumhofer, J. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.011 · Cited by 482
Regulation of Interleukin 12 p40 Expression through an NF-κB Half-Site
Murphy, T. L., Cleveland, M. G., Kulesza, P., Magram, J., & Murphy, K. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5258 · Cited by 482
Mattner, F., Magram, J., Ferrante, J., Launois, P., Padova, K. D., Behin, R., Gately, M. K., Louis, J. A., & Alber, G. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260722 · Cited by 469
T cell genetic background determines default T helper phenotype development in vitro.
Hsieh, C. S., Macatonia, S. E., O'Garra, A., & Murphy, K. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.713 · Cited by 462
Manetti, R., Gerosa, F., Giudizi, M. G., Biagiotti, R., Parronchi, P., Piccinni, M. P., Sampognaro, S., Maggi, E., Romagnani, S., & Trinchieri, G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1273 · Cited by 436
Reversibility of T helper 1 and 2 populations is lost after long-term stimulation.
Murphy, E., Shibuya, K., Hosken, N., Openshaw, P., Maino, V, Davis, K., Murphy, K., & O'Garra, A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.901 · Cited by 435
Developmental commitment to the Th2 lineage by extinction of IL-12 signaling
Szabo, S. J., Jacobson, N. G., Dighe, A. S., Gubler, U., & Murphy, K. M. (1995) · Immunity · doi:10.1016/1074-7613(95)90011-x · Cited by 421
High-level IL-12 production by human dendritic cells requires two signals
Snijders, A. (1998) · International Immunology · doi:10.1093/intimm/10.11.1593 · Cited by 420
An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection
Wynn, T. A., Cheever, A. W., Jankovic, D., Poindexter, R. W., Caspar, P., Lewis, F. A., & Sher, A. (1995) · Nature · doi:10.1038/376594a0 · Cited by 403
Role of cytokines in determining T-lymphocyte function
O'Garra, A., & Murphy, K. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90128-7 · Cited by 393
Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo.
Pfeiffer, C., Stein, J., Southwood, S., Ketelaar, H., Sette, A., & Bottomly, K. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1569 · Cited by 388
Restoration of HIV-Specific Cell-Mediated Immune Responses by Interleukin-12 in Vitro
Clerici, M., Lucey, D. R., Berzofsky, J. A., Pinto, L. A., Wynn, T. A., Blatt, S. P., Dolan, M. J., Hendrix, C. W., Wolf, S. F., & Shearer, G. M. (1993) · Science · doi:10.1126/science.7903123 · Cited by 384
Self-citationZimmermann, S., Egeter, O., Hausmann, S., Lipford, G. B., Röcken, M., Wagner, H., & Heeg, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3627 · Cited by 367
Genetic Susceptibility to Leishmania : IL-12 Responsiveness in T H 1 Cell Development
Güler, M. L., Gorham, J. D., Hsieh, C.-S., Mackey, A. J., Steen, R. G., Dietrich, W. F., & Murphy, K. M. (1996) · Science · doi:10.1126/science.271.5251.984 · Cited by 364
Reiner, S. L., Zheng, S., Wang, Z. E., Stowring, L., & Locksley, R. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.447 · Cited by 363
Belkaid, Y., Mendez, S., Lira, R., Kadambi, N., Milon, G., & Sacks, D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.969 · Cited by 363
Gurunathan, S., Sacks, D. L., Brown, D. R., Reiner, S. L., Charest, H., Glaichenhaus, N., & Seder, R. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1137 · Cited by 360
Murphy, E. E., Terres, G., Macatonia, S. E., Hsieh, C. S., Mattson, J., Lanier, L., Wysocka, M., Trinchieri, G., Murphy, K., & O'Garra, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.223 · Cited by 360
Selective Suppression of Interleukin-12 Induction after Macrophage Receptor Ligation
Sutterwala, F. S., Noel, G. J., Clynes, R., & Mosser, D. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.11.1977 · Cited by 351
Leishmania species: models of intracellular parasitism
Alexander, J., Satoskar, A. R., & Russell, D. G. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.18.2993 · Cited by 350
Flesch, I. E., Hess, J. H., Huang, S., Aguet, M., Rothe, J., Bluethmann, H., & Kaufmann, S. H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1615 · Cited by 345
Feng, G.-J., Goodridge, H. S., Harnett, M. M., Wei, X.-Q., Nikolaev, A. V., Higson, A. P., & Liew, F.-Y. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6403 · Cited by 335
Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase.
Stenger, S., Donhauser, N., Thüring, H., Röllinghoff, M., & Bogdan, C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1501 · Cited by 331
Soares, H., Waechter, H., Glaichenhaus, N., Mougneau, E., Yagita, H., Mizenina, O., Dudziak, D., Nussenzweig, M. C., & Steinman, R. M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070176 · Cited by 316
Carrera, L., Gazzinelli, R. T., Badolato, R., Hieny, S., Muller, W., Kuhn, R., & Sacks, D. L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.515 · Cited by 315
Belkaid, Y., Von Stebut, E., Mendez, S., Lira, R., Caler, E., Bertholet, S., Udey, M. C., & Sacks, D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.3992 · Cited by 311
Decken, K., Köhler, G., Palmer-Lehmann, K., Wunderlin, A., Mattner, F., Magram, J., Gately, M. K., & Alber, G. (1998) · Infection and Immunity · doi:10.1128/iai.66.10.4994-5000.1998 · Cited by 311
Manca, C., Tsenova, L., Barry, C. E., Bergtold, A., Freeman, S., Haslett, P. A. J., Musser, J. M., Freedman, V. H., & Kaplan, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6740 · Cited by 306
Cousens, L. P., Orange, J. S., Su, H. C., & Biron, C. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.634 · Cited by 304
Launois, P., Maillard, I., Pingel, S., Swihart, K. G., Xénarios, I., Acha-Orbea, H., Diggelmann, H., Locksley, R. M., MacDonald, H. R., & Louis, J. A. (1997) · Immunity · doi:10.1016/s1074-7613(00)80342-8 · Cited by 302
Kamanaka, M., Yu, P., Yasui, T., Yoshida, K., Kawabe, T., Horii, T., Kishimoto, T., & Kikutani, H. (1996) · Immunity · doi:10.1016/s1074-7613(00)80435-5 · Cited by 294
IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice
Biedermann, T., Zimmermann, S., Himmelrich, H., Gumy, A., Egeter, O., Sakrauski, A. K., Seegmüller, I., Voigt, H., Launois, P., Levine, A. D., et al. (2001) · Nature Immunology · doi:10.1038/ni725 · Cited by 294
Tacchini-Cottier, F., Zweifel, C., Belkaid, Y., Mukankundiye, C., Vasei, M., Launois, P., Milon, G., & Louis, J. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2628 · Cited by 291
Proinflammatory and Immunoregulatory Functions of Interleukin-12
Trinchieri, G. (1998) · International Reviews of Immunology · doi:10.3109/08830189809043002 · Cited by 290
Cousens, L. P., Peterson, R., Hsu, S., Dorner, A., Altman, J. D., Ahmed, R., & Biron, C. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1315 · Cited by 290
Grewe, M., Walther, S., Gyufko, K., Czech, W., Schöpf, E., & Krutmann, J. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12321078 · Cited by 289
Schmitt, E., Hoehn, P., Huels, C., Goedert, S., Palm, N., Rüde, E., & Germann, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240403 · Cited by 287
McMahon‐Pratt, D., & Alexander, J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00190.x · Cited by 283
Sellers, R. S., Clifford, C. B., Treuting, P. M., & Brayton, C. (2012) · Veterinary Pathology · doi:10.1177/0300985811429314 · Cited by 278
IL-4-deficient Balb/c mice resist infection with Leishmania major.
Kopf, M., Brombacher, F., Köhler, G., Kienzle, G., Widmann, K. H., Lefrang, K., Humborg, C., Ledermann, B., & Solbach, W. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1127 · Cited by 273
Finkelman, F. D., Madden, K. B., Cheever, A. W., Katona, I. M., Morris, S. C., Gately, M. K., Hubbard, B. R., Gause, W. C., & Urban, J. F. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1563 · Cited by 273
Evaluation of New Vaccines in the Mouse and Guinea Pig Model of Tuberculosis
Baldwin, S. L., D’Souza, C., Roberts, A. D., Kelly, B. P., Frank, A. A., Lui, M. A., Ulmer, J. B., Huygen, K., McMurray, D. M., & Orme, I. M. (1998) · Infection and Immunity · doi:10.1128/iai.66.6.2951-2959.1998 · Cited by 272
Hamano, S., Himeno, K., Miyazaki, Y., Ishii, K., Yamanaka, A., Takeda, A., Zhang, M., Hisaeda, H., Mak, T. W., Yoshimura, A., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00298-x · Cited by 264
Kamogawa, Y., Minasi, L.-A. E., Carding, S. R., Bottomly, K., & Flavell, R. A. (1993) · Cell · doi:10.1016/0092-8674(93)90542-x · Cited by 257
Jankovic, D., Kullberg, M. C., Hieny, S., Caspar, P., Collazo, C. M., & Sher, A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00278-9 · Cited by 252
Doolan, D. L., & Hoffman, S. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.884 · Cited by 183
Padigel, U. M., Kim, N., Choi, Y., & Farrell, J. P. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5437 · Cited by 36
“The development of a dominant Th1 response is dependent upon the proinflammatory cytokine IL-12 as evidenced by the inability of animals lacking the IL-12 gene (4) or mice treated with Ab to IL-12 (5, 6) to resolve infection, and by the demonstration that treatment with recombinant IL-12 promotes healing in highly sus…”
Background
Metadata
- Authors
- Sypek, J. P., Chung, C. L., Mayor, S. E., Subramanyam, J. M., Goldman, S. J., Sieburth, D. S., Wolf, S. F., & Schaub, R. G.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1993-06-01
- Volume
- 177
- Issue
- 6
- Pages
- 1797-1802
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2153552716
- Cited by
- 720
- References
- 16
- FWCI
- 89.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.